FAP and neoplasm: [177Lu]Lu-FAPI-02 biodistribution studies showed the highest uptake at 2 h after administration in human FAP-transfected HT-1080 tumor-bearing mice; however, the retention time of [177Lu]Lu-FAPI-02 in the tumor was relatively short and might not be enough to achieve a therapeutic response.